Business Context and Reporting Period
This Form 8-K reports the consummation of the initial public offering (IPO) by Bleichroeder Acquisition Corp. II, a Cayman Islands-based special purpose acquisition company (SPAC). The report date is January 7, 2026, with the IPO closing on January 9, 2026. The Company is an emerging growth company.
Key Financial Metrics
- Gross Proceeds: $287,500,000 from the sale of 28,750,000 Units at $10.00 per Unit (including full exercise of the over-allotment option).
- Private Placement Proceeds: $7,750,000 from the sale of 7,750,000 Private Placement Warrants at $1.00 per warrant.
- Trust Account Funding: $287,500,000 deposited into a U.S.-based trust account. This amount includes up to $12,250,000 of deferred underwriting discounts.
- Warrant Exercise Price: $11.50 per share for public warrants.
- Revenue/Profit/Cash Flow: The filing does not provide historical revenue, profit, or operating cash flow data as this is a pre-business combination SPAC.
Material Changes and Corporate Actions
- Capital Structure: Issued 28,750,000 Units (each consisting of one Class A ordinary share and one-third of one redeemable warrant) and 7,750,000 Private Placement Warrants.
- Board Appointments: Antoine Theysset and Kathy Savitt were appointed to the Board of Directors, joining Andrew Gundlach. Ms. Savitt was appointed Chair of both the Audit and Compensation Committees.
- Agreements: Entered into definitive agreements including an Underwriting Agreement, Warrant Agreement, Investment Management Trust Agreement, Registration Rights Agreement, and various Private Placement Warrant Purchase Agreements.
- Corporate Governance: Filed amended and restated memorandum and articles of association effective January 7, 2026.
Outlook, Risks, and Contingencies
- Business Combination Deadline: The Company has 24 months from the IPO closing to complete an initial business combination.
- Liquidity and Redemption: Funds in the trust account are generally restricted until the completion of a business combination, a shareholder vote to amend the charter, or a liquidation if the combination is not completed within the 24-month window.
- Use of Funds: Interest earned on the trust account may be released to pay taxes and winding-up expenses. The deferred underwriting discount is contingent on the completion of a business combination.
- Indemnification: The Company entered into indemnity agreements with directors and executive officers.
Investor Verification Checklist
- Verify the exact amount of deferred underwriting discount ($12,250,000) and its impact on net proceeds available for operations.
- Confirm the specific terms of the 24-month deadline for the initial business combination and any potential extension mechanisms.
- Review the Amended and Restated Memorandum and Articles of Association (Exhibit 3.1) for redemption rights and shareholder protections.
- Assess the financial strength and track record of the Sponsor (Bleichroeder Sponsor 2 LLC) and the underwriters (Cohen & Company Capital Markets).
- Monitor the status of the trust account and any withdrawals for tax or administrative expenses.